With a fresh infusion of personality, smarts and expertise, a new Alexa − officially, Alexa+ − is about to transform Amazon’s smart home control center from simple command-taker to a perky ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

In 2023, the market was valued at $340.4m, and it is projected to grow at a CAGR of 40.2% from 2024 to 2030. Renal denervation involves a catheter-based device being inserted into the femoral artery ...

The test assists doctors in the early detection of at-risk individuals with diabetic kidney disease. Credit: SewCreamStudio / Shutterstock ... In June 2024, the company announced a collaboration with ...

The treatment of kidney stones could soon be getting much faster, easier, and safer. Scientists have devised a method of non-invasively tearing the objects apart, using swirling sound waves called ...

In addition, the size and portability of this device would make the treatment of kidney stones an outpatient procedure without the need for large accessory equipment, as is currently the case.

In addition, the size and portability of this device would make the treatment of kidney stones an outpatient procedure without the need for large accessory equipment, as is currently the case.

According to the tests, its application halves the time needed to break up a stone. In addition, the size and portability of this device would make the treatment of kidney stones an outpatient ...

3B’s Research Group, I3Bs - Research Institute on Biomaterials, Biodegradables and Biomimetics of University of Minho, AvePark, Parque de Ciência e Tecnologia, Rua Ave 1, Edificio 1 (Sede), Barco, ...

Chronic kidney disease (CKD) refers to gradual kidney damage that reduces the kidneys’ ability to filter blood. CKD progresses through stages 1 to 5. Stage 4 CKD is the final stage before ...

This acquisition could bring Boston Scientific into the now-competitive renal denervation (RDN ... the THRIVE global FDA investigational device exemption (IDE) pivotal trial for Tivus.